Curcumin has been suggested as a promising treatment for metabolic diseases, but the high doses required limit its therapeutic use. In this study, a new curcuminoid is synthesised to increase curcumin anti-inflammatory and antioxidant potential and to achieve hypoglycaemic and protective vascular effects in type 2 diabetic rats in a lower dose. In vitro, the anti-inflammatory effect was determined through the G...
Made available in DSpace on 2021-06-25T11:16:28Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-01-01; Agence Nationale Des Parcs Nationaux; Centre for International Forestry Research; Departamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS); David and Lucile Packard Foundation; European Space Agency; Leverhulme Trust; Gordon and Betty Moore Foundation; Fundação de Amparo à Pesquisa ...